Inhibition of Yes-Associated Protein by Verteporfin Ameliorates Unilateral Ureteral Obstruction-Induced Renal Tubulointerstitial Inflammation and Fibrosis
Yes-associated protein (YAP) activation after acute ischemic kidney injury might be related to interstitial fibrosis and impaired renal tubular regeneration. Verteporfin (VP) is a photosensitizer used in photodynamic therapy to treat age-related macular degeneration. In cancer cells, VP inhibits TEA...
Main Authors: | Jixiu Jin, Tian Wang, Woong Park, Wenjia Li, Won Kim, Sung Kwang Park, Kyung Pyo Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/21/8184 |
Similar Items
-
The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth
by: Sarah Morice, et al.
Published: (2020-12-01) -
Verteporfin: A Novel Antiproliferative Agent for Urinary Tract Fibrosis?
by: Jas Singh
Published: (2022-01-01) -
The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor
by: Changran Wei, et al.
Published: (2020-10-01) -
Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas
by: Jeffrey D. Rytlewski, et al.
Published: (2021-02-01) -
Loss of Proximal Tubular Sirtuin 6 Aggravates Unilateral Ureteral Obstruction-Induced Tubulointerstitial Inflammation and Fibrosis by Regulation of β-Catenin Acetylation
by: Jixiu Jin, et al.
Published: (2022-04-01)